Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05825482 · ClinicalTrials.gov registry record · NA
Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout®
A NA study of Breast Cancer, sponsored by Case Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 204
- Enrollment target
- 1
- Study location
NCT05825482: Recruiting NA study of Breast Cancer, sponsored by Case Comprehensive Cancer Center.
NCT05825482 is a NA study of Breast Cancer that is actively recruiting participants, run by Case Comprehensive Cancer Center. The registered enrollment target is 204 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05825482, a NA study of Breast Cancer, is actively recruiting participants, sponsored by Case Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 204 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective study comparing partial mastectomy performed with routine cavity shave margins and Savi Scout® localization to partial mastectomy performed with selective margins and Savi Scout® localization. The primary objective is to determine the difference in positive margin rate between the two methods. The secondary objectives are to determine the differences in the rate of re-excision, volume of tissue extracted and Breast-Q® score between the two methods. It is hypothesized that the Savi Scout® will allow for decreased volume of tissue excised when compared to routine cavity shave margins without any difference in positive margin rate or rate of re-excision.
Primary Outcome
The primary objective is to determine the difference in positive margin rate between the two methods.
Conditions Studied
Interventions
- PROCEDURE Arm 1 Partial mastectomy with Savi Scout® localization and shave margins.
- PROCEDURE Arm 2 Partial mastectomy with Savi Scout® localization and selective shave margins.
Study Locations (1)
Ohio
- Cleveland Clinic Akron General, Case Comprehensive Cancer Center - Akron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 204 participants |
| Start Date | 2023-07-17 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT05825482 shows while recruiting
NCT05825482 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Arm 1 Partial mastectomy with Savi Scout® localization and shave margins. is the first listed.
NCT05825482 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05825482 about?
NCT05825482 is a clinical study titled "Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout®". This is a prospective study comparing partial mastectomy performed with routine cavity shave margins and Savi Scout® localization to partial mastectomy performed with selective margins and Savi Scout® localization. The primary objective is to determine the difference in positive margin rate between ...
What is the current status of trial NCT05825482?
This trial is currently recruiting. It is a NA study. The enrollment target is 204 participants. The study started on 2023-07-17. Estimated completion is 2026-03.
What conditions does trial NCT05825482 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT05825482?
The interventions under investigation include: Arm 1 Partial mastectomy with Savi Scout® localization and shave margins. (PROCEDURE), Arm 2 Partial mastectomy with Savi Scout® localization and selective shave margins. (PROCEDURE).
Who is sponsoring clinical trial NCT05825482?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05825482 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05825482's enrollment target sits among peer trials
204 359th of 1224 higher than 865 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03481010 · 204 participants · NA
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
- NCT04249830 · 204 participants · NA
Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults
- NCT04503395 · 204 participants · NA
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
- NCT04793776 · 204 participants · NA
Manage Emotions to Reduce Aggression (MERA)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI